Fluconazole vs Itraconazole for Pityriasis Versicolor
Treatments studied
Part of Infections, Skin clinical trials.
This study compares two common antifungal pills, fluconazole and itraconazole, to see which works better for treating pityriasis versicolor, a skin condition that causes discolored patches. If you have this condition and are generally healthy, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with pityriasis versicolor (a fungal skin infection causing light or dark patches).
- You have no serious kidney, liver, or heart problems, and you are not being treated for cancer or having chemotherapy or radiation.
- You have not used any antifungal medication (pills, creams, or shampoos) in the past month.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two common treatments for pityriasis versicolor, a fungal skin condition that causes light or dark patches: a cream applied to the skin versus an oral tablet. The goal is to see which works better in clearing the patches.
This study compares two medicated creams to treat pityriasis versicolor, a common fungal skin condition that causes discolored patches. You may be eligible if you have this condition and are generally healthy.
This study compares using a 2% ketoconazole shampoo for seven days versus three days to treat pityriasis versicolor, a common fungal skin condition that causes lighter or darker patches. The goal is to see which treatment duration works better at clearing the fungus.
This Phase 1 study tests how safe and how well a 20% cassia alata (a plant extract) cream works for tinea versicolor, a common skin condition. You may be able to join if your rash matches the study’s confirmed diagnosis and you have not used treatment recently.
This study compares two treatments for a common fungal skin infection called tinea (ringworm). One group gets itraconazole alone, the other gets itraconazole plus isotretinoin. The goal is to see which approach clears the infection faster, safer, and with a higher cure rate.
This study compares two treatments for widespread vitiligo: one is a combination of light therapy and a medication called Psoralen (PUVA), and the other is a pill called Tofacitinib (a JAK inhibitor) that may help restore skin color. The goal is to see which treatment works better and is safer for adults with stable vitiligo affecting a large area of the body.
Hear when a new Pityriasis Versicolor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.